From the Editors' Desk

3M Microneedles are a New Patient-Friendly Drug Delivery Method

Getting an injection at the doctor’s office typically does not rank high on many people’s wish list. Thanks to 3M scientists’ know-how, the day is getting closer when patients may be receiving their prescription...

Impax Receives FDA Approval for a Generic Version of Lamictal

Impax Laboratories, Inc., Hayward, CA, announced January 26 that the U.S. Food and Drug Administration (FDA) has approved generic Lamictal (lamotrigine) Orally Disintegrating Tablets, 25mg, 50mg, 100mg and 200mg in blister packaging. Impax will...

Global Nutraceuticals Market Driven by Emerging Markets

The global market for nutraceuticals shows healthy growth. A combination of nutrition and pharmaceuticals referring to food or medicinal products that provide health and/or medicinal benefits, including prevention of diseases, the nutraceuticals...

High-Potency Product Offerings Widen at Catalent Pharma Solutions

Catalent Pharma Solutions is expanding its potent handling and manufacturing capabilities at its Somerset, NJ, facility. The company can now support high-potency compounds from optimization through clinical and commercial manufacturing of final dose...

Major Machinery Maker Invests in Aseptic Pharmaceutical Packaging

Pianoro, Bologna - In a rather unstable economic context, that of 2014, the results of the Marchesini Group went totally against the flow and especially against the trends of the manufacturing market. The consolidated turnover of the Group (...

Dr. Robert Califf Named FDA Deputy Commissioner for Medical Products and Tobacco

U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D., has appointed Robert Califf, M.D., a recognized global leader in cardiology, clinical research, and medical economics, as FDA Deputy Commissioner for Medical Products and...

New Report Analyzes Trends in Lyophilized Drugs

DUBLIN, January 23, 2015 /PRNewswire/ -- ...

NanoViricides Ships anti-Ebola Drug Candidates For Testing

 

NanoViricides, Inc., West Haven, CT, a nanomedicine company developing anti-viral drugs, reported that it has shipped several anti-Ebola nanoviricide® drug candidates to a hi-security bio-containment facility in the...